CN103403187A - 结肠直肠癌复发的预后特征 - Google Patents

结肠直肠癌复发的预后特征 Download PDF

Info

Publication number
CN103403187A
CN103403187A CN2012800105712A CN201280010571A CN103403187A CN 103403187 A CN103403187 A CN 103403187A CN 2012800105712 A CN2012800105712 A CN 2012800105712A CN 201280010571 A CN201280010571 A CN 201280010571A CN 103403187 A CN103403187 A CN 103403187A
Authority
CN
China
Prior art keywords
seq
recurrence
patient
prognosis
analytical system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012800105712A
Other languages
English (en)
Chinese (zh)
Inventor
P·F·里赫汉
W·P·沃泽尔
A·阿尔莫
D·W·弗莱
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Everist Genomics Inc
Original Assignee
Everist Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Everist Genomics Inc filed Critical Everist Genomics Inc
Publication of CN103403187A publication Critical patent/CN103403187A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CN2012800105712A 2011-01-18 2012-01-17 结肠直肠癌复发的预后特征 Pending CN103403187A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161433798P 2011-01-18 2011-01-18
US61/433,798 2011-01-18
PCT/US2012/021539 WO2012099872A1 (en) 2011-01-18 2012-01-17 Prognostic signature for colorectal cancer recurrence

Publications (1)

Publication Number Publication Date
CN103403187A true CN103403187A (zh) 2013-11-20

Family

ID=46516038

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012800105712A Pending CN103403187A (zh) 2011-01-18 2012-01-17 结肠直肠癌复发的预后特征

Country Status (10)

Country Link
US (1) US9234245B2 (enExample)
EP (1) EP2665835B1 (enExample)
JP (1) JP2014503222A (enExample)
KR (1) KR20140040694A (enExample)
CN (1) CN103403187A (enExample)
AU (1) AU2012207442B2 (enExample)
CA (1) CA2825046A1 (enExample)
IL (1) IL227419A (enExample)
MX (1) MX2013008252A (enExample)
WO (1) WO2012099872A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109073651A (zh) * 2016-04-20 2018-12-21 希罗普罗布股份公司 结肠直肠癌分类的标志物基因、判断淋巴结转移以预后结肠直肠癌的方法及用于其的试剂盒
CN109929934A (zh) * 2019-03-27 2019-06-25 中山大学附属第六医院 免疫相关基因在结直肠癌预后的试剂盒和系统中的应用
CN111321221A (zh) * 2018-12-14 2020-06-23 中国医学科学院肿瘤医院 用于预测直肠癌局部切除手术后复发风险的组合物、微阵列和计算机系统

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6757560B2 (ja) * 2014-09-26 2020-09-23 シスメックス株式会社 大腸癌の再発リスク診断を補助する方法、プログラムおよびコンピュータシステム
US10900084B2 (en) 2015-09-16 2021-01-26 Sysmex Corporation Method for supporting diagnosis of risk of colorectal cancer recurrence, treatment of colorectal cancer, and administration of anticancer drug
EP3743534B1 (en) 2018-01-22 2022-03-23 Liquid Biopsy Research LLC Methods for colon cancer detection and treatment monitoring
IL311084A (en) * 2018-11-30 2024-04-01 Caris Mpi Inc New generation molecular characterization
CN113436741B (zh) * 2021-07-16 2023-02-28 四川大学华西医院 基于组织特异增强子区域dna甲基化的肺癌复发预测方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005085861A2 (en) * 2004-03-03 2005-09-15 Oridis Biomed Forschungs- Und Entwicklungs Gmbh Nucleic acids and encoded polypeptides for use in liver disorders and epithelial cancer
WO2006071983A2 (en) * 2004-12-29 2006-07-06 Mannkind Corporation Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines
US20060257902A1 (en) * 2005-03-25 2006-11-16 Ambion, Inc. Methods and compositions for depleting abundant RNA transcripts
CN1910292A (zh) * 2003-10-03 2007-02-07 Ncc技术投资私人有限公司 涉及乳癌诊断的材料和方法
WO2008021290A2 (en) * 2006-08-09 2008-02-21 Homestead Clinical Corporation Organ-specific proteins and methods of their use
WO2010109168A2 (en) * 2009-03-23 2010-09-30 Academisch Ziekenhuis Leiden Also Acting Under The Name "Leiden University Medical Center" (Lumc) Angiogenesis methods, medicaments and agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
GB9425138D0 (en) * 1994-12-12 1995-02-08 Dynal As Isolation of nucleic acid
US20020068277A1 (en) * 1998-11-20 2002-06-06 Simpson Andrew John George Method for determining nucleotide sequences using arbitrary primers and low stringency
AU2003222221A1 (en) * 2002-02-15 2004-10-25 The General Hospital Corporation Map-kinase inhibitors as regulators of tumour-associated antigen expression
EP2080140B1 (en) * 2006-11-03 2013-04-24 Baylor Research Institute Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis
AT504702A1 (de) * 2006-12-22 2008-07-15 Arc Austrian Res Centers Gmbh Set von tumormarkern
JP2010178650A (ja) * 2009-02-04 2010-08-19 Univ Of Tokyo 固形癌の再発予測のための試験方法および再発予防剤

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1910292A (zh) * 2003-10-03 2007-02-07 Ncc技术投资私人有限公司 涉及乳癌诊断的材料和方法
WO2005085861A2 (en) * 2004-03-03 2005-09-15 Oridis Biomed Forschungs- Und Entwicklungs Gmbh Nucleic acids and encoded polypeptides for use in liver disorders and epithelial cancer
WO2006071983A2 (en) * 2004-12-29 2006-07-06 Mannkind Corporation Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines
US20060257902A1 (en) * 2005-03-25 2006-11-16 Ambion, Inc. Methods and compositions for depleting abundant RNA transcripts
WO2008021290A2 (en) * 2006-08-09 2008-02-21 Homestead Clinical Corporation Organ-specific proteins and methods of their use
WO2010109168A2 (en) * 2009-03-23 2010-09-30 Academisch Ziekenhuis Leiden Also Acting Under The Name "Leiden University Medical Center" (Lumc) Angiogenesis methods, medicaments and agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TOSHIAKI WATANABE ET AL.: "Gene Expression Signature for Recurrence in Stage III Colorectal Cancers", 《CANCER》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109073651A (zh) * 2016-04-20 2018-12-21 希罗普罗布股份公司 结肠直肠癌分类的标志物基因、判断淋巴结转移以预后结肠直肠癌的方法及用于其的试剂盒
CN111321221A (zh) * 2018-12-14 2020-06-23 中国医学科学院肿瘤医院 用于预测直肠癌局部切除手术后复发风险的组合物、微阵列和计算机系统
CN111321221B (zh) * 2018-12-14 2022-09-23 中国医学科学院肿瘤医院 用于预测直肠癌局部切除手术后复发风险的组合物、微阵列和计算机系统
CN109929934A (zh) * 2019-03-27 2019-06-25 中山大学附属第六医院 免疫相关基因在结直肠癌预后的试剂盒和系统中的应用
CN109929934B (zh) * 2019-03-27 2022-09-09 中山大学附属第六医院 免疫相关基因在结直肠癌预后的试剂盒和系统中的应用

Also Published As

Publication number Publication date
AU2012207442B2 (en) 2017-02-23
EP2665835B1 (en) 2018-03-14
MX2013008252A (es) 2014-04-14
IL227419A0 (en) 2013-09-30
JP2014503222A (ja) 2014-02-13
IL227419A (en) 2017-01-31
AU2012207442A1 (en) 2013-08-01
US9234245B2 (en) 2016-01-12
US20120185174A1 (en) 2012-07-19
CA2825046A1 (en) 2012-07-26
KR20140040694A (ko) 2014-04-03
EP2665835A4 (en) 2016-07-20
EP2665835A1 (en) 2013-11-27
WO2012099872A1 (en) 2012-07-26

Similar Documents

Publication Publication Date Title
US20220396842A1 (en) Method for using gene expression to determine prognosis of prostate cancer
US10196691B2 (en) Colon cancer gene expression signatures and methods of use
US8440407B2 (en) Gene expression profiles to predict relapse of prostate cancer
US9234245B2 (en) Prognostic signature for colorectal cancer recurrence
US10113201B2 (en) Methods and compositions for diagnosis of glioblastoma or a subtype thereof
US20170044618A1 (en) Methods and compositions involving intrinsic genes
CN101743327B (zh) 黑色素瘤的预后预测
EP2767595A1 (en) Detection method for characterising the anatomical origin of a cell
CN113736879A (zh) 用于小细胞肺癌患者预后的系统及其应用
EP1683862B1 (en) Microarray for assessing neuroblastoma prognosis and method of assessing neuroblastoma prognosis
US20090297506A1 (en) Classification of cancer
CN103060348A (zh) 用于检测原发性肝癌的复发潜力的基因标志物
WO2018098241A1 (en) Methods of assessing risk of recurrent prostate cancer
HK1191675A (en) Prognostic signature for colorectal cancer recurrence
HK1145342B (en) Prognosis prediction for melanoma cancer
NZ612471B2 (en) Colon cancer gene expression signatures and methods of use

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1191675

Country of ref document: HK

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20131120

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1191675

Country of ref document: HK